Duan L - Search Results

1

Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.

Han C, Yang WZ, Zhang HT, Ye T, Duan L. Han C, et al. Among authors: duan l. J Clin Neurosci. 2015 Feb;22(2):286-90. doi: 10.1016/j.jocn.2014.05.046. Epub 2014 Oct 28. J Clin Neurosci. 2015. PMID: 25443089

2

Association of a functional polymorphism in the MMP-3 gene with Moyamoya Disease in the Chinese Han population.

Li H, Zhang ZS, Liu W, Yang WZ, Dong ZN, Ma MJ, Han C, Yang H, Cao WC, Duan L. Li H, et al. Among authors: duan l. Cerebrovasc Dis. 2010;30(6):618-25. doi: 10.1159/000319893. Epub 2010 Oct 15. Cerebrovasc Dis. 2010. PMID: 20948207

3

Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: a case-control study.

Li H, Zhang ZS, Dong ZN, Ma MJ, Yang WZ, Han C, Du MM, Liu YX, Yang H, Liu W, Duan L, Cao WC. Li H, et al. Among authors: duan l. Stroke. 2011 Apr;42(4):1138-9. doi: 10.1161/STROKEAHA.110.608471. Epub 2011 Feb 24. Stroke. 2011. PMID: 21350209

4

Moyamoya disease in China: its clinical features and outcomes.

Duan L, Bao XY, Yang WZ, Shi WC, Li DS, Zhang ZS, Zong R, Han C, Zhao F, Feng J. Duan L, et al. Stroke. 2012 Jan;43(1):56-60. doi: 10.1161/STROKEAHA.111.621300. Epub 2011 Oct 20. Stroke. 2012. PMID: 22020027

5

Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.

Bao XY, Duan L, Li DS, Yang WZ, Sun WJ, Zhang ZS, Zong R, Han C. Bao XY, et al. Among authors: duan l. Cerebrovasc Dis. 2012;34(4):305-13. doi: 10.1159/000343225. Epub 2012 Nov 8. Cerebrovasc Dis. 2012. PMID: 23146868

6

Coexistence of moyamoya and Graves' diseases: the clinical characteristics and treatment effects of 21 Chinese patients.

Li D, Yang W, Xian P, Liu P, Bao X, Zong R, Duan L. Li D, et al. Among authors: duan l. Clin Neurol Neurosurg. 2013 Sep;115(9):1647-52. doi: 10.1016/j.clineuro.2013.02.018. Epub 2013 Mar 19. Clin Neurol Neurosurg. 2013. PMID: 23518423

7

Prospective screening of family members with moyamoya disease patients.

Han C, Feng H, Han YQ, Liu WW, Zhang ZS, Yang WZ, Duan L. Han C, et al. Among authors: duan l. PLoS One. 2014 Feb 19;9(2):e88765. doi: 10.1371/journal.pone.0088765. eCollection 2014. PLoS One. 2014. PMID: 24586386 Free PMC article.

8

Recent progress in hemorrhagic moyamoya disease.

Wan M, Duan L. Wan M, et al. Among authors: duan l. Br J Neurosurg. 2015 Apr;29(2):189-91. doi: 10.3109/02688697.2014.976177. Epub 2014 Nov 3. Br J Neurosurg. 2015. PMID: 25365664 Review.

9

Identification of a hemodynamic parameter for assessing treatment outcome of EDAS in Moyamoya disease.

Karunanithi K, Han C, Lee CJ, Shi W, Duan L, Qian Y. Karunanithi K, et al. Among authors: duan l. J Biomech. 2015 Jan 21;48(2):304-9. doi: 10.1016/j.jbiomech.2014.11.029. Epub 2014 Nov 29. J Biomech. 2015. PMID: 25498370

10

Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China.

Bao XY, Duan L, Yang WZ, Li DS, Sun WJ, Zhang ZS, Zong R, Han C. Bao XY, et al. Among authors: duan l. Cerebrovasc Dis. 2015;39(2):75-81. doi: 10.1159/000369524. Epub 2015 Jan 6. Cerebrovasc Dis. 2015. PMID: 25573764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,895 results

Search Page

Filters